Loading clinical trials...

Combining Non-Invasive Brain Stimulation With Cognitive Behavioral Intervention in Substance Use Disorder | Clinical Trials | Clareo Health

WITHDRAWNNA

Combining Non-Invasive Brain Stimulation With Cognitive Behavioral Intervention in Substance Use Disorder

NCT02570763•University of Minnesota

View on ClinicalTrials.gov

Summary

The current study aims to examine the safety and feasibility of utilizing tDCS to enhance affect-laden episodic memory consolidation among adults with co-occurring alcohol use and anxiety disorders who have recently undergone detoxification as a step toward the translational clinical application of this approach.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•DSM IV diagnosis of panic disorder (with or without agoraphobia), generalized anxiety disorder, or social anxiety disorder within the past 30 days
•DSM IV diagnosis of alcohol dependence within the last 30 days
•inpatient treatment at Lodging Plus primarily for alcohol (vs. other drug) dependence
•alcohol use in the 30 days preceding the study
•willingness to provide informed consent
•minimum of a sixth grade English reading level (deemed necessary to complete study materials); as determined by their being able to read and understand the consent form.
•Living within reasonable driving distance (1 hour or less) of the Twin Cities to allow for in-person follow-up interviews

Exclusion Criteria

•lifetime history of psychosis or mania by history.
•cognitive (e.g., dementia) or physical impairment (e.g., blindness) that interferes with study participation report or as judged by PI/study physician.
•Current suicide risk as deemed by the PI and study physician to be serious and ongoing
•any medical condition or treatment with neurological sequelae (e.g., stroke, tumor, loss of consciousness of more than 30 minutes, HIV, seizures)
•history of ECT
•document loss of consciousness (LOC) for longer than 30 minutes or LOC with neurological sequelae
•pregnancy
•Although seizures are not a known risk of tDCS intervention (Fregni et al., 2006; Nitsche et al., 2008), anyone with a history or a risk for seizures will be excluded from the study
•anyone with metal objects implanted in their head or neck
•anyone taking stimulant medications for any reason as we wish to avoid two sorces of neurostimulation

Key Dates

Start Date

November 1, 2015

Primary Completion Date

July 1, 2016

Completion Date

July 1, 2016

Last Updated

November 6, 2017

Conditions

Active tDCSSham tDCS

Interventions

Active tDCS stimulation

DEVICE

Sham tDCS stimulation

DEVICE

Combination of Neurostimulation and Psychotherapy to Stop Worrying

NCT06369532

Active tDCSSham tDCS

View study

COMPLETEDNA

Supporting Decisions With Transcranial Direct Current Stimulation in Healthy Young and Elderly Individuals

NCT03959462

Real tDCSSham tDCS

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 6, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Combining Non-Invasive Brain Stimulation With Cognitive Behavioral Intervention in Substance Use Disorder

Inclusion Criteria

Exclusion Criteria

Combination of Neurostimulation and Psychotherapy to Stop Worrying

Supporting Decisions With Transcranial Direct Current Stimulation in Healthy Young and Elderly Individuals

Neuromodulation Augmented Cognitive Training to Improve Cognitive Flexibility in Anorexia Nervosa